The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates in Malta, a country with a high incidenceof methicillin resistance, was studied by screening454 non-repetitive S. aureus isolates on teicoplanin-supplemented agar plates, followed by Etestsand genotypic studies. All strains were susceptibleto vancomycin, but four (0.88%) exhibitedteicoplanin MICs of > 12 mg? L. High methicillinresistantS. aureus endemicity was not an accuratepredictor of the emergence of non-susceptibilityto glycopeptides
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinic...
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinic...
PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermediate resistance (VISA...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
ABSTRACTThe incidence of hetero-intermediate glycopeptide susceptibility among Staphylococcus aureus...
Objectives To determine the incidence of Staphylococcus aureus isolates with reduced susceptibility ...
Multidrug resistant Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of nosocomia...
Incidence of vancomycin intermediate Staphylococcus aureus (VISA) and vancomycin hetero-intermediate...
According to the French Society of Microbiology, Staphylococcus aureus isolates are suspected to hav...
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been reported fro...
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been reported fro...
International audienceOBJECTIVES: Glycopeptides are the drugs of choice to treat infections due to m...
ObjectiveTo reassess the relative potencies of teicoplanin and vancomycin following several years of...
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinic...
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinic...
PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermediate resistance (VISA...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
ABSTRACTThe incidence of hetero-intermediate glycopeptide susceptibility among Staphylococcus aureus...
Objectives To determine the incidence of Staphylococcus aureus isolates with reduced susceptibility ...
Multidrug resistant Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of nosocomia...
Incidence of vancomycin intermediate Staphylococcus aureus (VISA) and vancomycin hetero-intermediate...
According to the French Society of Microbiology, Staphylococcus aureus isolates are suspected to hav...
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been reported fro...
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been reported fro...
International audienceOBJECTIVES: Glycopeptides are the drugs of choice to treat infections due to m...
ObjectiveTo reassess the relative potencies of teicoplanin and vancomycin following several years of...
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinic...
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinic...
PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermediate resistance (VISA...